AJM Pharma is committed to community's health by providing medicines with quality and affordability
AJM's core strategy is to introduce a new market of highly effective molecules and lifesaving drugs at an affordable price and holds awareness campaigns to educate patients and medical professionals.
Vision: To serve the community progressively and be among top pharmaceutical companies.
Mission: To provide quality products of International standards at affordable cost.
AJM Pharma (Pvt.) Limited founded in 2004, is part of ICS Group of Companies. AJM Pharma derives its strength from the world known principals it has acquired over the years following their best practice methodology as AJM forte.
AJM Pharma works in following specialities
AJM Pharma deals in Oncology, Thalassaemia, Gastroenterology, Nephrology, HIV/AIDS & Gynaecology
Letara (Letrozole) is indicated for first line treatment of postmenopausal women with hormone receptor positive or harmone receptor unknown, locally advanced or metastatic breast cancer.
It contains zoledronic acid, a bisphosphonic acid that is an inhibitor of osteoclastic bone resorption. It is indicated for the treatment of patients with multiple myeloma and also indicated for the treatment of hypercalcaemia of malignancy.
Oderox (Deferasirox) is breakthrough in oral iron chelation therapy. Its unique features include, dispersible tablet, once-daily dosage, high chelating efficacy, generally well tolerated.
Recombinant human erythropoietin injection - Most effective and safe therapy agent for anaemia associated with chronic renal failure. It is demonstrated to be similar with innovator in terms of quality, efficacy and safety.
Capecitabine is indicated as a single agent for adjuvant treatment in patients with Dukes'C colon cancer, also as first-line treatment of patients with matastatic colorectal carcinoma.